Literature DB >> 24232868

[Rhinorrhea following laryngectomy : Treatment with botulinum toxin type A.]

J Winterhoff1, A Gehrt, C Matthias, R Laskawi.   

Abstract

After laryngectomy, the transport of intranasal secretions is often inadequate due to the lack of the nasal ventilation. Consequently, persistent and disruptive anterior rhinorrhea may occur. We report the case of a 61-year-old man who had recently undergone a laryngectomy and who was successfully treated with bilateral injections of botulinum toxin into the anterior portion of the inferior turbinates. After treatment, rhinorrhea was clearly reduced. Therefore, symptomatic treatment of anterior rhinorrhea with local injections of botulinum toxin type A should be considered as an option to improve the quality of life in laryngectomized patients.

Entities:  

Year:  2013        PMID: 24232868     DOI: 10.1007/s00106-013-2717-0

Source DB:  PubMed          Journal:  HNO        ISSN: 0017-6192            Impact factor:   1.284


  8 in total

1.  Minimally invasive application of botulinum toxin type A in nasal hypersecretion.

Authors:  S Rohrbach; R Laskawi
Journal:  ORL J Otorhinolaryngol Relat Spec       Date:  2001 Nov-Dec       Impact factor: 1.538

2.  [Botulinum toxin for the treatment of secretory disorders of the head and neck area].

Authors:  A Steffen
Journal:  HNO       Date:  2012-06       Impact factor: 1.284

3.  The effect of intranasal injection of botulinum toxin A on the symptoms of vasomotor rhinitis.

Authors:  Cengiz Ozcan; Yusuf Vayisoglu; Okan Doğu; Kemal Görür
Journal:  Am J Otolaryngol       Date:  2006 Sep-Oct       Impact factor: 1.808

4.  Ipratropium bromide nasal spray for treatment of rhinorrhea in the laryngectomized patient: a pilot study.

Authors:  T M Magardino; D Suskind-Liu; H Kroger; N Mirza
Journal:  Am J Rhinol       Date:  2001 May-Jun

5.  The effect of botulinum toxin type A injection for intrinsic rhinitis.

Authors:  K S Kim; S S Kim; J H Yoon; J W Han
Journal:  J Laryngol Otol       Date:  1998-03       Impact factor: 1.469

6.  Effect of botulinum toxin type A on nasal symptoms in patients with allergic rhinitis: a double-blind, placebo-controlled clinical trial.

Authors:  Murat Unal; Serhan Sevim; Okan Doğu; Yusuf Vayisoğlu; Arzu Kanik
Journal:  Acta Otolaryngol       Date:  2003-12       Impact factor: 1.494

7.  Incidence of sinunasal disease in laryngectomized patients.

Authors:  Andreas M Sesterhenn; Gordon Fiedler; Hans-Helge Müller; Susanne Wiegand; Benedikt J Folz; Jochen A Werner
Journal:  ORL J Otorhinolaryngol Relat Spec       Date:  2008-04-08       Impact factor: 1.538

8.  Minimally invasive application of botulinum toxin A in patients with idiopathic rhinitis.

Authors:  Saskia Rohrbach; Katharina Junghans; Sibylle Köhler; Rainer Laskawi
Journal:  Head Face Med       Date:  2009-10-16       Impact factor: 2.151

  8 in total
  1 in total

Review 1.  [Botulinum toxin in otorhinolaryngology - an update].

Authors:  R Laskawi; A Olthoff
Journal:  HNO       Date:  2017-10       Impact factor: 1.284

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.